CIPLA's weekly performance was relatively stable, with a modest return of 0.07%, outperforming its peers SUNPHARMA, DIVISLAB, and GRASIM. The stock's volatility was relatively high at 15.66%, indicating moderate risk. Compared to its peers, CIPLA's Sharpe Ratio of 0.02 suggests it was less risky and more efficient in generating returns. Overall, CIPLA's performance was resilient amidst a challenging week for its peers.

[Volatility: 15.66%]